FlyAmanita - Amanita Muscaria mushroom-related production, retail, research, and healthcare project.
The Problem
1. Analgesics (painkillers) are designed and widely used to treat mild or severe pain. This market is growing at ±6% CAGR and is estimated to reach $91B in 2025.
2. Mental health issues are common to about 11% of mankind and has been recently propelled 4 times by the Covid-19 pandemic. 4 out of 10 people have some kind of mental issue (depression, anxiety, bipolar or eating disorder, drug, alcohol use, schizophrenia, etc). Most people with these issues are located in N. America, W. Europe, and Australia.
The Opportunity
The demand for painkillers, antidepressants and psychotherapy services is huge and will continue to grow, so all kinds of natural/homeopathic medicine and therapies will be in constantly increasing need. Natural healing properties of Amanita Muscaria make it a great opportunity to homeopathically treat (chronic) pain and key mental issues - anxiety and depression.
The Mushroom - natural painkiller, antidepressant and so much more
Amanita muscaria, commonly known as Fly Amanita or Fly Agaric, is a muscimol mushroom and is best known for its hallucinogenic, pain-killing, and antidepressant properties. It contains compounds as Muscimol, Ibotenic Acid, and Muscarine and is actually known to man for centuries since many countries of the Southern Hemisphere used those for various shamanic events and treatment.
Over time there have been lots of discovered and proven benefits of Amanita Muscaria mushroom, which nowadays is actually quite popular among Silicon Valley audience:
• Natural pain-killing and antidepressant properties, immune system boost, and Mycelium-based antimicrobial properties.
• Increased energy, strength, endurance, and virility, euphoria, bliss, happiness.
• Effectiveness against arthritis, sore throat, Lyme disease (caused by infected ticks). Has purge and detox properties.
• Helps with menopause issues as well as subdued over-excitability, bladder, and intestinal cramps.
• Helps deal with addictions and dependencies by providing a smoother way out. Also could be used against hangovers.
Milestones
Amanita Muscaria itself is a bit controversial due to its hallucinogenic properties, but it is legal in most countries (excluding Australia, Romania, The Netherlands, Thailand, and Louisiane State in the US). Its wide selection of healing, antidepressant, immune-boosting and other properties makes it a good basis for a few use-cases that Fly Amanita is determined to exploit.
#1 Pharmacy market: the production of chemical compounds
There is a high pharmaceutical industry's demand for Muscimol, Ibotenic acid, and Muscarine chemical compounds (more info on those is provided further in this document). Even though the compounds are expensive (all compounds cost over $1000 for 100mg) the extraction of those out of Amanita Muscaria mushrooms is relatively easy without the need of high-tech laboratories.
#2 Research of Application for Rehabilitation
This is a long-term goal that will last for at least 1-2 years. It will first start as a research project aiming to explore and find safe Amanita Muscaria related real-life applications for rehabilitation of chronic pain, insomnia, menstrual pain, post-traumatic stress, lack of confidence, self-esteem, productivity, depression, and many more. There have been poor or if not unexplored opportunities of Amanita Muscaria Mushroom application for rehabilitation. To achieve this Fly Amanita is determined to assemble a team of experts of chronic pain, holistic medicine, biochemistry, holistic medicine, psychotherapy, and others as well as volunteers for rehabilitation application tests.
#3 Rehabilitation service and Center
Once those applications are found and are safe to use, FlyAmanita is determined to start offering this as a healthcare service (mostly with supervision) in both offline and online options. FlyAmanita has also a very ambitious will to establish a physical rehabilitation center in the project's home town of Siauliai, Lithuania (EU), where FLY holders would, of course, have special deals and priority access opportunities. Lithuania is literally in the middle of Europe with good aviation access, but in case of success, this rehab center would then have the potential to expand its network to other countries as well.
Whitepaper
Sales
Ended